Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB

Prostate

Volumn 71, Issue 13, 2011, Pages 1420-1428

  Cavazos, David A ^a   Price, Ramona S ^a   Apte, Shruti S ^a   Degraffenried, Linda A ^a  

^a The University of Texas at Austin   (United States)

Author keywords

DNA damage; NF B; omega 3 fatty acids; oxidative stress; prostate cancer

Indexed keywords

CASPASE; DOCOSAHEXAENOIC ACID; DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMEGA 3 FATTY ACID; REACTIVE OXYGEN METABOLITE; SURVIVIN;

ADULT; ARTICLE; CARCINOMA CELL; CASE REPORT; CELL DEATH; CELL GROWTH; CELL LINE; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLONY FORMATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; DOCOSAHEXAENOIC ACIDS; HUMANS; HYDROGEN PEROXIDE; INHIBITOR OF APOPTOSIS PROTEINS; MALE; NF-KAPPA B; OXIDATIVE STRESS; PROSTATIC NEOPLASMS;

EID: 80051669972     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21359     Document Type: Article

References (22)

1. McEntee MF, Ziegler C, Reel D, Tomer K, Shoieb A, Ray M, Li X, Neilsen N, Lih FB, O'Rourke D, et al. Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer. Am J Pathol 2008; 173 (1): 229-241. (Pubitemid 351947970)
2. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J,. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16 (7): 1364-1370. (Pubitemid 47076865)
3. Virtanen JK, Mozaffarian D, Chiuve SE, Rimm EB,. Fish consumption and risk of major chronic disease in men. Am J Clin Nutr 2008; 88 (6): 1618-1625.
4. Mori M, Masumori N, Fukuta F, Nagata Y, Sonoda T, Sakauchi F, Ohnishi H, Nojima M, Tsukamoto T,. Traditional Japanese diet and prostate cancer. Mol Nutr Food Res 2009; 53 (2): 191-200.
5. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS,. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 2008; 17 (4): 930-937. (Pubitemid 351536425)
6. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T,. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141 (8): 732-740.
7. El-Mesery M, Al-Gayyar M, Salem H, Darweish M, El-Mowafy A,. Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): Implications of CRP and lipid peroxides. Cell Div 2009; 4: 6.
8. Fradet V, Cheng I, Casey G, Witte JS,. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 2009; 15 (7): 2559-2566.
9. Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, Choudhury GG, Ghosh-Choudhury N,. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat 2009; 118 (1): 213-228.
10. Hardman WE,. Omega-3 fatty acids to augment cancer therapy. J Nutr 2002; 132 (11 Suppl): 3508S-3512S. (Pubitemid 35315828)
11. Cusack JC Jr, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J, Baldwin AS Jr., Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: Implications for systemic nuclear factor-kappaB inhibition. Cancer Res 2001; 61 (9): 3535-3540. (Pubitemid 32694955)
12. Basu S, Rosenzweig KR, Youmell M, Price BD,. The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem Biophys Res Commun 1998; 247 (1): 79-83. (Pubitemid 28412529)
13. Shaikh IA, Brown I, Schofield AC, Wahle KW, Heys SD,. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF-kappaB pathway. Prostate 2008; 68 (15): 1635-1646.
14. Wu JD, Lin DW, Page ST, Lundgren AD, True LD, Plymate SR,. Oxidative DNA damage in the prostate may predispose men to a higher risk of prostate cancer. Transl Oncol 2009; 2 (1): 39-45.
15. deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, Roth RA, Hidalgo M,. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. Clin Cancer Res 2004; 10 (23): 8059-8067. (Pubitemid 39587547)
16. Chou TC, Talalay P,. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
17. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK,. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008; 68 (6): 1777-1785. (Pubitemid 351416563)
18. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW 3rd, Kang L, Rabinovitch PS, Szeto HH, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009; 119: 573-581.
19. Frisard M, Ravussin E,. Energy metabolism and oxidative stress: Impact on the metabolic syndrome and the aging process. Endocrine 2006; 29 (1): 27-32. (Pubitemid 43780344)
20. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH,. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
21. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I,. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114 (12): 1752-1761. (Pubitemid 40385531)
22. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22 (3): 439-445. (Pubitemid 41079772)